Literature DB >> 26382050

Gastric residual volume after split-dose compared with evening-before polyethylene glycol bowel preparation.

Deepak Agrawal1, Benjamin Elsbernd2, Amit G Singal1, Don Rockey3.   

Abstract

BACKGROUND AND AIMS: Split-dose bowel preparation for colonoscopy results in superior preparation quality. However, some endoscopy units remain hesitant to prescribe split-dose preparation given theoretical concerns about possible aspiration caused by gastric residual fluid when a second dose is given close to the time of endoscopy. Our aim was to compare gastric residual volume (GRV) in patients taking split-dose bowel preparation and those taking preparation the evening before colonoscopy.
METHODS: We performed a prospective observational comparison of GRV among random inpatients undergoing same-day EGD and colonoscopy either after a split-dose bowel preparation or after a bowel preparation the prior evening.
RESULTS: GRV was measured in 150 patients undergoing EGD and colonoscopy: 75 who completed a split-dose bowel preparation 2 to 3 hours before endoscopy and 75 who completed the bowel preparation regimen the prior evening. The mean GRV 2 to 3 hours after the last ingestion of bowel preparation among split-dose group patients was 21 ± 24 mL (± standard deviation; range, 0 to 125 mL), which was not different from the mean GRV of 24 ± 22 mL (range, 0 to 135 mL) in patients who ingested the preparation the prior evening (P = .08). GRV had no association with the presence of diabetes, gastroparesis, or opioid use.
CONCLUSIONS: GRV is the same after a split preparation and fasting for 2 to 3 hours or after preparation with overnight fasting. The data suggest that the risk of aspiration is identical after either preparation technique and thus that sedation for colonoscopy can be performed safely 2 hours after bowel preparation ingestion.
Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26382050     DOI: 10.1016/j.gie.2015.08.081

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  6 in total

1.  Gastric Residual Volume after Split-Dose Bowel Preparation versus Conventional Single-Dose Regimen before Anesthetic Colonoscopy.

Authors:  Shi-Gui Xue; Han-Lin Chen; Chun-Sheng Cheng; Bao-Sheng Huang; Hou-de Zhang
Journal:  Biomed Res Int       Date:  2017-12-24       Impact factor: 3.411

2.  A patient-centered framework for health systems engineering in gastroenterology: improving inpatient colonoscopy bowel preparation.

Authors:  Alexandra T Strauss; Jennifer Yeh; Diego A Martinez; Gayane Yenokyan; Janet Yoder; Ravi Nehra; Tara Feller; Kathy Bull-Henry; Ellen Stein; Lawrence C H Hsu; Haitham Al-Grain; Candice Zabko; Christopher Fain
Journal:  BMC Gastroenterol       Date:  2021-02-27       Impact factor: 3.067

3.  Multi-center study of residual gastric volume and bowel preparation after the usage of 1L and 2L polyethylene glycol in Korea.

Authors:  Yong Eun Park; Su Jin Jeong; Jin Lee; Jongha Park; Seung Jung Yu; Sam Ryong Jee; Tae Oh Kim
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

Review 4.  Optimizing bowel preparation for colonoscopy: a guide to enhance quality of visualization.

Authors:  Matthew L Bechtold; Fazia Mir; Srinivas R Puli; Douglas L Nguyen
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun

5.  IMPlementing split Regimen OVEr Single dose using a Plan-Do-Study-Act approach (IMPROVES study).

Authors:  Giuseppe Vanella; Cesare Hassan; Mario De Bellis; Maxemiliano Giardini; Enrico Grasso; Francesco Laterza; Ottaviano Tarantino; Emilio Di Giulio
Journal:  Endosc Int Open       Date:  2019-10-22

6.  Evaluation of pH and residual gastric volume after colon preparation with mannitol: prospective randomized study comparing procedure performed after 3 hours versus 6 hours.

Authors:  Renzo Feitosa Ruiz; Jose Jukemura; Paulo Roberto Arruda Alves; Marcos Eduardo Lera Dos Santos
Journal:  Clinics (Sao Paulo)       Date:  2020-11-11       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.